Editas: Q4 Earnings Snapshot

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $60.7 million in its fourth quarter.

The Cambridge, Massachusetts-based company said it had a loss of 88 cents per share.

The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.

The genome editing company posted revenue of $6.5 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $4.6 million.

For the year, the company reported that its loss widened to $220.4 million, or $3.21 per share. Revenue was reported as $19.7 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up